NBCNEWS.com | June 17, 2020
Calethia Hodges has an arduous task: persuade Black people who have a deep mistrust of experimental drugs and medical institutions to participate in clinical trials to help find a vaccine for the deadly coronavirus.
It is quite the paradox. African Americans have been disproportionately devastated by COVID-19, but they are inadequately represented in human studies that would treat a disease that has claimed more than 116,000 lives in the United States. Almost a quarter of those were Black, according to a study called Color of Coronavirus by APM Research Lab…
Medium.com | May 28, 2020
As a part of my series about the things we can do to remain hopeful and support each other during anxious times, I had the pleasure of interviewing Ms. Calethia Hodges.
Calethia T. Hodges is the founder and CEO of Infinite Clinical Trials, LLC. Prior to founding, Infinite Clinical Trials, Ms. Hodges executed large scale, global clinical development portfolios…
RollingOut.com | May 18, 2020
For more than a decade, Calethia Hodges has strategically led the growth and development of service firms supporting biopharma clinical research and functional domains. Today, she is CEO of Infinite Clinical Trials, two clinical research firms outside Atlanta, and is one of the city’s experts on COVID-19.
One of the few African American women in her field, Hodges has a Bachelor of Science degree from DePaul University and…
Slate.com | May 08, 2020
Calethia Hodges wants the people in her community to know what’s going on with their bodies. As the director of clinical operations for Infinite Clinical Trials, a 4,000-square-foot research facility in Morrow, Georgia, on the southeastern edge of the Atlanta metro area, Hodges spends a lot of time and resources attempting to recruit Black people for clinical medical trials—a demographic that is woefully underrepresented, even if the illness that researchers are attempting to treat disproportionately affects them…
